Crossbow Therapeutics

Crossbow Therapeutics

  • Founded: 2021
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Drug types: ONC
  • Product link: https://www.crossbowtx.com/
  • Funding: $80M A Jul 2023
  • Investors: MPM BioImpact, Pfizer Ventures, Polaris Partners, BVF Partners, Eli Lilly, Mirae Asset Venture Investment, Mirae Asset Capital


crossbowtx.com

linkedin.com


Short description:

Antibody Therapies

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

The mission of Crossbow Therapeutics is to cure cancer. Their team is developing highly potent and accurate antibody-based therapies to target tumor-specific peptides. They are developing next-generation immunotherapies, called T-Bolt therapies, utilizing T cell receptor-memetic antibodies. Crossbow was founded in 2021 by co-founders Geraldine Paulus, Patrick Baeuerle, and Todd Foley.

Jobs:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com